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region F is unknown. The amino-terminal A/B regionsMireille Rossignol, Jean-Marc Egly
and Pierre Chambon of RARs and RXRs contain a ligand-independent tran-
scriptional activation function, AF-1 (Nagpal et al., 1993).Institut de GeÂ neÂ tique et de Biologie
MoleÂculaire et Cellulaire The B regions of the three RAR isotypes are well con-
served, but their amino-terminal A regions are unrelatedCentre National de la Recherche Scientifique
Institut National de la SanteÂ et de la and different for each isoform of a given RAR isotype
(Leid et al., 1992). For a given isotype, the activity ofRecherche MeÂdicale
UniversiteÂ Louis Pasteur AF-1 and AF-2, as well as their synergism, exhibits some
specificity that can be dependent on both the cell typeColleÁ ge de France
BP 163 and the promoter context of RA-responsive genes. In
addition, the AF-1 and AF-2 of the various RARs appear67404 Illkirch Cedex Strasbourg
France to be significantly different from each other (Nagpal et
al., 1992, 1993). Several putative intermediary factors
(coactivators) that might relay the AF-2 activity to acti-
vate the Pol II general transcription machinery and/or toSummary
derepress the chromatin template of responsive genes
have been characterized (Chambon, 1996; Glass et al.,The activity of the N-terminal activation function AF-1
1997). In contrast, little is known about the molecularof RARa1 is abrogated upon mutation of a phosphor-
mechanisms through which AF-1 synergistically acti-ylatable serine residue (Ser-77). Recombinant RARa
vates initiation of transcription.was phosphorylated by a variety of proline-directed
Nuclear receptors are phosphoproteins. Their phos-protein kinases in vitro. However, only the coexpres-
phorylation may be instrumental in the cross-talk be-sion of cdk7 stimulated Ser-77 phosphorylation in vivo
tween the NR signaling pathways and other signalingand enhanced transactivation by RARa, but not by a
pathways, but in general, no clear relationship betweenS77A RAR mutant. Both free CAK (cdk7, cyclin H,
the phosphorylation of a specific amino acid residueMAT1) and the CAK-containing general transcription
and a given NR function has been yet establishedfactor TFIIH phosphorylated Ser-77 in vitro. Further-
(Weigel, 1996). However, the activity of the estrogenmore RARa bound free CAK and purified TFIIH in vitro,
receptor (ER) AF-1 is dependent on phosphorylation ofand RARa±TFIIH complexes could be isolated from
a highly conserved serine residue present in region B,HeLa nuclear extracts. These findings represent the
and it was shown that this phosphorylation could befirst example of activation of a transactivator through
induced by growth factors and transduced by mem-binding to and phosphorylation by a general transcrip-
brane-bound receptor tyrosine kinases through the Ras/tion factor.
Raf/MAPK cascade (Kato et al., 1995).
We previously reported that RARs are phosphopro-Introduction
teins (Rochette-Egly et al., 1991, 1995; Gaub et al., 1992).
RARa1 overexpressed in transfected Cos-1 cells isThe highly diverse effects of retinoids are transduced
phosphorylated on multiple serine residues, irrespectiveby two classes of ligand-dependent transactivators, the
of the presence of RA, and treatment with forskolin in-retinoic acid (RA) receptors (RARs) and the retinoid X
duces the phosphorylation of a consensus PKA sitereceptors (RXRs), which belong to the superfamily of
located in the LBD (Rochette-Eglyet al., 1995; see Figurenuclear receptors (NRs) (Gronemeyer and Laudet, 1995;
1A). In a recent study (Taneja et al., submitted), we reportMangelsdorf and Evans, 1995; Chambon, 1996). The
that RARa1 AF-1 is essential for RA-induced parietalthree RAR (a, b, and g) and the three RXR (a, b, and
endodermal differentiation of F9 cells, and that a puta-g) isotypes are encoded by different genes, and their
tive proline-directed phosphorylation site that includesmultiple isoforms, which differ in their N-terminal A re-
serine 77 (Ser-77) is critically required for AF-1 activitygions, are generated by differential promoter usage and
in this differentiation model system. We show here thatalternative splicing. RARs are activated by all trans RA
several putative phosphorylation sites for proline-(tRA) and its 9-cis isomer (9C-RA), while RXRs are acti-
directed kinases, located in RARa B and F regions (Fig-vated by 9C-RA only. Several lines of evidence support
ure 1A), are constitutively phosphorylated in transfectedthe conclusionthat RXR/RARheterodimers are the func-
Cos-1 cells. We demonstrate that the phosphorylationtional units transducing the retinoid signal in vivo (Kast-
of Ser-77 is selectively stimulated by cdk7 in transfectedner et al., 1995; Chambon, 1996; Clifford et al., 1996).
cells, and that the activity of AF-1 is concomitantly in-As do all members of the superfamily, retinoid recep-
creased. Furthermore, cdk7 associated with the generaltors exhibit a conserved modular organization with six
transcription factor TFIIH efficiently phosphorylatedhomology regions (A±F) (Figure 1A; Leid et al., 1992;
Ser-77 and, most interestingly, endogenous RARa wasChambon, 1996). The highly conserved region C corre-
found associated with TFIIH in HeLa cells, thus showingsponds to the core of the DNA-binding domain (DBD).
that the activity of a transactivator could be modulatedRegion E is functionally complex as it contains the li-
gand-binding domain (LBD), the ligand-dependent tran- through its interaction with a general transcription
factor.scriptional activation function AF-2 (Nagpal et al., 1993),
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Results trypsic digests. RARaWT (Figure 1C, panel 1) yielded
4 phosphopeptides (a±d), of which phosphopeptide a,
which was lacking in RARaDAB (panel 2), was the onlyIdentification of RARa Residues Phosphorylated
by Proline-Directed Kinases one to be present in RARaDF (panel 3). Identical phos-
phopeptide patterns were obtained whether or notThere are several putative phosphorylation sites for pro-
line-directed kinases (Pdks) in mouse RARa1 (Figure 1A; Cos-1 cells were treated with RA (data not shown).
The serine residues of the putative phosphorylationidentical sites are present in human RARa1). To identify
the phosphorylated sites, Cos-1 cells were transfected sites were then individually mutated to alanine (Figure
1A). The level of phosphorylation and the phosphopep-with either wild-type mRARa1 (RARaWT), mRARa1 de-
leted for the A/B region (RARaDAB), or mRARa1 deleted tide map of RARaS74A were not significantly different
from those of RARaWT (Figure 1B, lanes 7 and 8; Figurefor the F region (RARaDF), and labeled with [32P]phos-
phate. RARaWT was similarly phosphorylated, irrespec- 1C, panels 1 and 4). On the other hand, RARaS77A was
less phosphorylated than RARaWT (Figure 1B, lanes 6tive of the addition of tRA to the culture medium (Figure
1B, lanes 1 and 2). Deletion of either the A/B or the F and 8), and phosphopeptide a was lacking (Figure 1C,
panel 5), indicating that Ser-77 is phosphorylated inregion decreased the level of phosphorylation (Figure
1B, compare lanes 4 and 5 with lane 3, for both 32P RARaWT. The level of phosphorylation of RARaS445A,
RARaS449A, RARaS456A, and RARaS461 did not ap-autoradiography and Western blotting), indicating that
both the A/B and F regions are phosphorylated. pear to be significantly different from that of RARaWT
(Figure 1B, lanes 9±13, and data not shown). However,The sites of phosphorylation were mapped in RARa
Figure 1. Phosphorylation of mRARa1 Ex-
pressed in Cos-1 Cells and Identification of
Phosphorylation Sites
(A) The putative phosphorylation sites of
mouse RARa1 are underlined, and the actu-
ally phosphorylated serines are marked by
an asterisk. The PKA site (Ser-369) is shown.
Arrows point to trypsin cleavage sites, and
the sequences of the different mutants are
indicated.
(B) Cos-1 cells, transfected with either wild-
type ([WT], lanes 1±3, 8, 9, and 12), DAB (lane
4), DF (lane 5), S74A (lane 7), S77A (lane 6),
S449A (lane 10), S456A (lane 11), or S461A
(lane 13) RARa1, were labeled with 32P, and
whole cell extracts (WCEs) were immuno-
precipitated with MAb20a(D2) (lanes 3±5) or
MAb9a(F) (lanes 1, 2, and 6±13). Immunopre-
cipitates were subjected to SDS±PAGE and
autoradiography (32P) and immunoblotting (WB)
with RPa(D2) (lanes 3±5) or RPa(F) (lanes 1,
2, and 6±13). In lane 2, cells were treated with
RA (1027 M) for 1 hr; similar results were ob-
tained with a 4 hr RA treatment (not shown).
(C) Two-dimensional tryptic phosphopeptide
map of 32P-labeled immunoprecipitated RARa
WT, RARaDAB, RARaDF, and mutated RARa
(as indicated).
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phosphopeptides b and d were lacking in RARaS461A et al., 1995) (data not shown), suggesting that the Ras-
MAPK cascade of the growth factor receptor tyrosine(Figure 1C, panel 6) and RARaS456A (panel 7), respec-
tively. Both serines 456 and 461 are located in the same kinase signaling pathway was not involved. The RARa
phosphorylation pattern was affected neither by coex-tryptic digest peptide, but phosphopeptide b appears
to be phosphorylated on Ser-461 only, and phospho- pression of an activated Ras (Ras Val12; Wasylyk et al.,
1988) nor by a dominant-negative Ras (Ras Asn17; Caipeptide d on Ser-456 only (Table 1, and see below).
Thus, Ser-456 and Ser-461 phosphorylation could be et al., 1990). Similarly, treatment of Cos-1 cells with EGF
did not alter this pattern (data not shown).mutually exclusive. Phosphopeptide c was missing in
both RARaS449A (panel 8) and RARaS445A (data not Coexpression of a dominant active cdk1 (Norbury et
al., 1991) had no effect on RARa phosphorylation (Figureshown), indicating a possible interdependence of the
phosphorylation of these residues. In any event, our 2A, lanes 1 and 3, and data not shown). Furthermore,
dominant-negative mutants of either cdk1 or cdk2,data indicate that serine 77 and serines 445, 449, 456,
and 461 can be sites for phosphorylation by Pdks (Table which block the activity of the corresponding cdks by
competing for essential interacting molecules such as1). Interestingly, phosphopeptide a was also seen in
trypsic digests of endogenous RARa of F9 embryonal cyclins (Van Den Heuvel and Harlow, 1993) and changed
the FACS cell cycle distribution, also had no effect (datacarcinoma (EC) cells (data not shown).
Phosphorylation of RARa Is Increased upon
Overexpression of cdk7, but Not
of Other cdks or MAP Kinase
Pdks include the cyclin-dependent protein kinases
(cdks) and the mitogen-activated protein kinases
(MAPKs) (Nigg, 1995; Robinson and Cobb, 1997). RARa
phosphorylation and phosphopeptide pattern were not
affected in Cos-1 cells by coexpressing either MAPK,
MAPK kinase, or the MAPK phosphatase CL100 (Kato
Table 1. Amino Acid Sequence of the RARa Tryptic
Phosphopeptides a, b, and d
Cycle Amino Acid Residue Yield (pmol)2
Peptide a1 1 Ileu-71 3.1
2 Val-72 2.8
3 Pro-73 3.1
4 Ser-74 0.7
5 Pro-75 2.5
6 Pro-76 2.6
7 Ser-77* 0*
8 Pro-78 2.7
9 Pro-79 2.7
10 Pro-80 2.7
11 Leu-81 1.1
12 Pro-82 2
13 Arg-83 0.8
Peptide b 1 Ser-455 3.0
2 Ser-456 2.3
3 Pro-457 0.34
4 Ala-458 0.22 Figure 2. RARa Phosphorylation Is Constant during the Cell Cycle
5 Thr-459 0.11 and Is Increased upon Overexpression of cdk7
6 Gln-460 0.21
(A) Cos-1 cells transfected with RARaWT, in the absence (lane 1)7 Ser-461* 0*
or presence of cdk7 (1 mg, lane 2) or cdk1 (1 mg, lane 3), without8 Pro-462 2.4
(lane 4) or with a 15 hr exposure to Nocodazol (50 ng/ml) (lane 5)
Peptide d 1 Ser-455 3.9 or Aphidicolin (5 mg/ml) (lane 6), were labeled with 32P. WCEs were
2 Ser-456* 0* immunoprecipitated with MAb9a(F) and processed as in Figure 1B
3 Pro-457 11.7 for autoradiography and immunoblotting with RPa(F).
4 Ala-458 2.5 (B) The position in the cell cycle of Cos-1 cells treated or not for 15
5 Thr-459 3.0 hr with Nocodazol or Aphidicolin was determined by FACS analysis.
6 Gln-460 3.3 (C) Phosphopeptide map of 32P-labeled RARaWT and RARaS77A
7 Ser-461 7.0 immunoprecipitated from Cos-1 cells cotransfected or not with cdk7
8 Pro-462 2.4 or cdk7m.
(D) Extracts of Cos-1 cells transfected with RARaWT in the absence*Denotes the phosphorylated residue as deduced from the drop in
(lane 1) or presence (lane 2) of cdk7 (cdk7 tag) were immunoprecipi-the yield of the dehydro-amino acid derivative.
tated with MAb-cdk7 and probed with both RPa(F) and MAb-cdk7.1 Purified RARaWT or RARaDAB were phosphorylated with cdk1/
Similarly, extracts from Cos-1 cells transfected with cdk1 in thecyclin B and subjected to tryptic phosphopeptide mapping. After
absence (lane 7) or presence (lane 8) of RARa were immunoprecipi-autoradiography, the phosphopeptides a, b, and d were recovered
tated with MAb-cdk1 and probed with both RPa(F) and MAb-cdk1.and processed as described in Experimental Procedures.
Lane 6 corresponds to control untransfected cells, and lanes 3±52 These values correspond to a representative experiment.
correspond to the unprecipitated initial extracts.
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not shown). As cdk1 (in association with cyclin B) is association of MAT1 to form the ternary CAK complex
(Nigg, 1996). Purified E. coli±expressed RARaWT wasrequired for the G2/M transition, while cdk2 and/or other
cdks are involved in initiation of DNA duplication (Nigg, indeed phosphorylated by a purified recombinant cdk7/
1995), we also investigated whether RARa phosphoryla- cyclin H complex (Figure 3A, compare lanes 1 and 2),and
tion might vary during the cell cycle. No significant effect this phosphorylation was enhanced by MAT1 addition
on RARa phosphorylation (Figure 2A, lanes 4±6) and (CAK complex) (compare lanes 2 and 3). Mutation of
phosphopeptide patterns (notshown) could be detected the cdk7 ATP binding site (cdk7m in CAKm) drastically
in Cos-1 cells blocked either at the mitosis prophase decreased RARa phosphorylation (lane 4).
stage (G2/M) by nocodazol or at the entry of S phase Interestingly, RARa was efficiently phosphorylated
(G1/S) by aphidicolin (Figure 2B). (Figure 3A, lanes 5 and 8) by highly purified holoTFIIH
In contrast, overexpression of cdk7 , whose level and (hydroxyapatite fraction, Fischer et al., 1992), a multi-
kinase activity are constant during the different phases subunit transcription factor that includes CAK (Hoeij-
of the cell cycle (Tassan et al., 1994; Adamczewski et makers et al., 1996; Svejstrup et al., 1996). RARaDAB
al., 1996), increased both the overall levelof RARa phos- was also phosphorylated by the CAK (Figure 3A, lane
phorylation (Figure 2A, lanes 1 and 2) and of phospho- 7) and TFIIH (data not shown) complexes. The corre-
peptides a±d (Figure 2C, panels 1 and 2). Phosphopep- sponding tryptic phosphopeptide map of CAK (not
tide a was lacking in the RARaS77A mutant (Figure 2C, shown)- or holoTFIIH (Figure 3B, panel 1)-phosphory-
panel 3), and no phosphorylation enhancement was ob- lated RARa revealed peptides a and b similar to those
served with a cdk7 ATP binding site mutant (Figure 2C, of RARa phosphorylated in Cos-1 cells (see above).
panel 4). Interestingly, in a control experiment aimed at Phosphopeptide a was not present in RARaDAB phos-
checking the expression of the transfected cdk1 and phorylated in vitro, while peptide b remained, and two
cdk7 vectors, RARa coimmunoprecipitated with cdk7, more weakly labeled peptides migrating as peptides c
but not with cdk1 (Figure 2D), suggesting that cdk7 and d appeared (Figure3B, panel 3).Thus, the A/Bregion
could not only phosphorylate RARa, but also stably bind may prevent phosphorylation in vitro of sites located in
to it (see below). region F. Note that phosphopeptide a was also lacking
in RARaS77A phosphorylated with CAK or TFIIH (Figure
3B, panel 2).In Vitro Phosphorylation of RARa by Proline-Directed
Protein Kinases and HoloTFIIH In fact, RARa appeared to be more efficiently phos-
phorylated by TFIIH-associated CAK than by free CAK,The activity of cdk7 is dependent on its association
with cyclin H (Morgan, 1995) and is stimulated by the as the TFIIH fraction used in Figure 3A (lanes 5, 8, and
Figure 3. In Vitro Phosphorylation of Bacteri-
ally Expressed RARa1 with cdk7, CAK, or
TFIIH
(A) Purified bacterially expressed RARaWT
(lanes 1±5) or RARaDAB (lanes 6±7) (1 mg)
was phosphorylated with either purified
cdk7/cyclin H complex (lane 2), purified cdk7/
cyclinH/MAT1 complex containing wild-type
(CAK, lanes 3 and 7) or mutated (CAKm, lane
4) cdk7, or highly purified TFIIH (lanes 5 and
8). Phosphorylated proteins were visualized
by autoradiography (lanes 1±8) and immu-
noblotting with RPa(F) and MAb-cdk7 (lanes
9±15). Lanes 1, 6, 9, and 14 correspond to
controls incubated in the absence of kinase.
Lane 8 is a shorter exposure (3 hr) of lane 5
(15 hr).
(B) Phosphopeptide map of RARaWT (a),
S77A (b), and DAB (c) phosphorylated by puri-
fied TFIIH.
(C) Purified bacterially expressed RARaWT
(1 mg, lanes 1±7, or 0.1 mg, lanes 8±15) was
phosphorylated with increasing amounts of
recombinant CAK or purified TFIIH, con-
taining comparable amounts of cdk7 as
checked by immunoblotting. Lanes 1 and 8,
controls incubated in the absence of kinase.
(D) Purified bacterially expressed RARaWT (1
mg) was phosphorylated with TFIIH further
purified by immunoprecipitation using pro-
tein A±Sepharose beads cross-linked with
MAb-p62 (lane 3). Controls were performed
with the same beads in the absence of RARa
(lane 2) and with RARa incubated in the ab-
sence of TFIIH (lane 1).
Activation of RARa through Phosphorylation by TFIIH
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13) contained much less cdk7 (as judged from immuno-
blotting) than the free CAK used in the same experiments
(lanes 3 and 11). This was confirmed by using TFIIH and
CAK complexes containing equivalent amounts of cdk7
as estimated by immunoblotting (Figure 3C, compare
lanes 2 and 7 and lanes 9±11 with lanes 13±15). Similar
results were obtained whether RARa was used in excess
(lanes 1±7) or in limiting (lanes 8±15) amounts. Note also
that, in agreement with the results of Rossignol et al.
(1997), cdk7 was more efficiently autophosphorylated
in TFIIH-associated CAK than in free CAK (Figure 3C,
compare lanes 9±11 with lanes 12±15). That RARa could
be more efficiently phosphorylated by TFIIH-associated
CAK was furthersupported by comparing its phosphory-
lation with that of cdk2, which has been shown to be
similarly phosphorylated by free and TFIIH-associated
CAK (Rossignol et al., 1997; Yankulov and Bentley, 1997)
(data not shown). Finally, RARa was also phosphory-
lated by a TFIIH fraction further purified by immunopre-
cipitation with monoclonal antibodies against its p62
subunit (Figure 3D), making it unlikely that a contaminat-
ing kinase could be responsible for the observed RARa
phosphorylation.
In contrast to the results obtained using transfected
Cos-1 cells (see above), both RARaWT and RARaDAB
could be phosphorylated in vitro by the cdk1/cyclin B
complex (data not shown). Identical phosphopeptide
maps were obtained for RARa phosphorylated with ei-
ther cdk1/cyclin B, CAK, or TFIIH (Figure 3B, and data
not shown). Phosphopeptide a was lacking in digests
of RARaDAB and RARaS77A, whereas phosphopeptide
b was not present in digests of RARaS461A, and both
polypeptides a and b were present in RARaS74A. Thus
Ser-77 in the A/B region and Ser-461 in the F region Figure 4. Coimmunoprecipitation of Endogenous RARa with cdk7
and the p62 Subunit of TFIIH in Extracts of HeLa Cellsappear to be the main in vitro phosphorylated RARa
(A) HeLa cells nuclear extracts (NEs) (2.5 mg) were immunoprecipi-residues.
tated (IP) with either MAb-p62 (lane 3), MAb-cdk7 (lane 4), orRARaWT, but not RARaDAB, was also phosphory-
MAbRARa(F) (lane 7) and immunoprobed with RPa(F) and MAb-lated in vitro by MAPK (data not shown). As expected,
cdk7. Controls were performed with a MAb-GST (lanes 2 and 6).
only phosphopeptide a was present in the correspond- Lanes 1 and 5, aliquots of the unprecipitated initial extracts.
ing tryptic digests of RARa, and RARaS77A could not (B) HeLa cell NEs (1.25 mg) were immunoprecipitated with
be phosphorylated by MAPK, indicating that the only MAbRARa(F) (lane 2) and immunoprobed with RPa(F), MAb-p62,
and MAb-cdk7. Lane 1, unprecipitated initial extract.RARa residue phosphorylatable by MAPK in vitro is ser-
(C) HeLa WCEs, immunoprecipitated with MAbRARa(F) (lane 3),ine 77.
MAb-cdk1 (lane 6), or MAb-GST (lanes 2 and 5), were probed with
RPa(F) and MAb-cdk1. Lanes 1 and 4, unprecipitated initial extract.
(D) HeLa WCEs were immunoprecipitated with MAbRXRa (lanes 1,RARa Binds to cdk7 and TFIIH 2, and 5), MAbRARa(F) (lanes 3 and 6), or MAb-GST (lanes 4 and
We noted above that RARa and cdk7 coexpressed in 7). Proteins were revealed using the indicated antibodies.
transfected Cos-1 cells apparently interacted (Figure
2D). Such interactions were further investigated with
HeLa cells extracts immunoprecipitated with MAb di- used. MAb-p62 immunoprecipitates contained not only
cdk7, as previously reported (Adamczewski et al., 1996),rected against RARa (the main RAR isotype in HeLa
cells) orcdk7, and analyzed by SDS±PAGE/immunoblot- but also RARa (Figure 4A, lane 3). Reciprocally, MAb-
RARa coimmunoprecipitated RARa, p62, and cdk7 (Fig-ting using RARa and cdk7 antibodies. MAb-RARa pre-
cipitated both RARa and cdk7 (Figure 4A, lane 7) and, ure 4B, lane 2), thus supporting the conclusion that
RARa interacted with TFIIH. Similar observations werereciprocally, MAb-cdk7 immunoprecipitated both cdk7
and RARa (Figure 4A, lane 4), whereas these proteins made using Cos-1 cell extracts (data not shown).
In fact, it appears that RARa may interact preferen-were not revealed in control immunoprecipitations car-
ried out with a MAb against the unrelated GST protein tially in HeLa cells with TFIIH-associated cdk7, as more
RARa was immunoprecipitated with MAb-p62 than with(lanes 2 and 6).
To investigate whether RARa bound to cdk7 of free MAb-cdk7 under conditions where the same amount of
cdk7 was immunoprecipitatedwith these two antibodiesCAK or of CAK within the holoTFIIH complex (composed
of nine subunits including CAK and p62; Svejstrup et (compare lanes 3 and 4, Figure 4A). It also appears that
only a fraction of cdk7 was associated with RARa, asal., 1996), MAbs against the p62 subunit (MAb-p62) were
Cell
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Figure 5. Interaction of Purified Bacterially
Expressed RARa with Purified Recombinant
cdk7 In Vitro
(A) Purified RARaWT (lane 2) or DAB (lane 5)
(0.5 mg), and crude bacterial extracts con-
taining RARaWT (lane 3) or RARaS77A (lane
4), were incubated with cdk7 immunoad-
sorbed onto beads cross-linked with MAb-
cdk7. Bound proteins were probed with
RPa(F) and MAb-cdk7. Controls were per-
formed in the absence of cdk7 (lane 1). Ali-
quots of unprecipitated RARa extracts were
probed with RPa(F) (lanes 6±9).
(B) The same beads as in (A) were incubated
with increasing amounts of RARaDAB (lanes
3±5) or RXRaDAB (lanes 7±9) and probed with
MAb-cdk7 and RPa(F) (lanes 1±5) or MAbRXRa
(lanes 6±9). Controls were performed in the
absence of cdk7 (lanes 2 and 6) and with
bacterially expressed GST immunoabsorbed
onto beads cross-linked with MAb-GST (lane
1). No coimmunoprecipitation of cdk7 and
RXRa was detected.
(C) Cdk7 (lanes 1 and 6), cdk7m (lane 2), CAK (lane 7), or purified holoTFIIH (three times the amount used in lane 11) (lane 5) containing
equal amounts of cdk7 as checked by immunoblotting (lanes 8±11) were incubated with RARa immunoadsorbed onto beads cross-linked
with MAbRARa(F). Retained proteins were probed with MAb-cdk7 and MAb-p62. Controls were performed in the absence of RARa (lanes 3
and 4).
(D) Cdk7 (see [C], lane 8) was incubated with RARaWT (lane 3) or RXRaDAB (lane 5) immunoabsorbed onto beads cross-linked with MAbRARa(F)
(lanes 2±3) or MAbRXRa (lanes 4±5), respectively. Retained proteins were probed with MAb-cdk7 and RPa(F) (lanes 1±3) or MAbRXRa
(lanes 4 and 5). Controls were performed with the same beads in the absence of RARa (lane 2) or RXRa (lane 4) and with GST beads as in
(B) (lane 1).
most of it remained in the supernatant after immunopre- similar interactions occurred between RARa and either
cdk7, cdk7m, CAK, or a highly purified preparation ofcipitation of the HeLa cell extracts with MAb-RARa; in
contrast, a large fraction of cdk7 could be precipitated holoTFIIH that does not contain any free CAK (hydroxy-
apatite fraction of Fischer et al., 1992) (compare laneswith MAb-p62, and all cdk7 was precipitated with MAb-
cdk7 (data not shown), in agreement with observations 1±7 in Figure 5C), thus corroborating that RARa and
holoTFIIH stably interact in vitro. These interactionsindicating that only a fraction of CAK is associated with
TFIIH (Drapkin et al., 1996; Reardon et al., 1996; Rossig- were specific, as neither cdk7 or RARa were retained by
the bacterially expressed GST protein immunoabsorbednol et al., 1997). Interestingly, no similar interactions
between RARa and either cdk1 or ERK1 and ERK2 onto beads cross-linked with MAb-GST, (Figure 5B, lane
1, and Figure 5D, lane 1). Moreover, the GST proteinMAPKs could be detected (Figure 4C, and data not
shown). was not retained on cdk7 or RARa beads (data not
shown).Using antibodies against RXRa, some cdk7 could also
be coimmunoprecipitated with RXRa (Figure 4D, lanes Purified bacterially expressed RARaDAB bound cdk7
more efficiently than RARaWT (Figure 5A, compare1 and 5) and the same antibodies also coimmunoprecipi-
tated a small fraction of RARa (Figure 4D, compare lanes lanes 2 and 5 with lanes 6 and 9; Figure 5B, lanes 3±5),
indicating that cdk7 may bind to an RARa region whose2 and 3). However, there was much less cdk7 coimmuno-
precipitating with RXRa than with RARa (Figure 4D, accessibility might be increased in the absence of the
A/B region. Note also that the S77A mutation had nocompare lanes 5 and 6), in keeping with the amount of
RARa immunoprecipitated with the RXRa antibodies. effect on the interaction between RARa and cdk7 (Figure
5A, lane 4). Under the same experimental conditions,As there does not seem to be any association between
cdk7 and RXRa either in vitro or in transfected cells (see purified bacterially expressed RXRaDAB did not interact
with cdk7 (Figure 5B, lanes 6±9, and Figure 5D, lanes 4below), this cdk7-RXRa coimmunoprecipitation most
probably reflects the binding of cdk7 to the RAR partner and 5).
Similar interactions were observed using cotrans-of RARa-RXRa heterodimers.
To demonstrate that RARa and cdk7 directly interact, fected Cos-1 cells. RARa (Figure 6A, lane 1, and Figure
6B, lane 10) was retained on cdk7 beads, but not onpurified bacterially expressed RARa was incubated with
recombinant cdk7 immunoabsorbed onto protein control (GST) beads (Figure 6A, lane 5, and Figure 6B,
lane 8). Moreover, neither the A/B region of RARa orA±Sepharose beads cross-linked with cdk7 antibodies.
RARa was retained on cdk7 beads (Figure 5A, lanes 2 residue Ser-77 appeared to be required for interaction
with cdk7 in cotransfected Cos-1 cells (Figure 6A, lanesand 3).Reciprocally, purified cdk7 was retained by RARa
immobilized onto protein A beads cross-linked with 1±3). In agreement with the above in vitro data, wild-
type RXRa did not interact with cdk7, when using eitherRARa antibodies (Figure 5C, lane 1), indicating that
RARa and cdk7 directly interact in vitro. Importantly, RXRa or cdk7 immunoaffinity beads (Figure 6B, lanes
Activation of RARa through Phosphorylation by TFIIH
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Figure 6. Interaction of RARa with cdk7 in Transfected Cos-1 Cells
(A) Extracts from Cos-1 cells transfected with RARaWT (lanes 1 and
5), RARaS77A (lane 2), or RARaDAB (lane 3) in the presence of cdk7
(cdk7tag) were precipitated with MAb-cdk7 (lanes 1±4) or control
MAb-GST (lane 5) and probed with RPa(F) and MAb-cdk7. Aliquots
of initial extracts were probed with RPa(F) (lanes 6±8).
(B) Extracts from control Cos-1 cells (lane 7) and from cells
transfected with either RXRa (lanes 1±6) or RARa (lanes 8±10) in
the presence (lanes 1, 3, 4, 6, 8, and 10) or absence (lanes 2, 5, and
9) of cdk7 were precipitated with either MAb-cdk7 (lanes 5, 6, 7, 9,
and 10), MAbRXRa (lanes 2 and 3), or MAb-GST (lanes 1, 4, and 8)
and probed with MAb-cdk7 and MAbRXRa (lanes 1±6) or RPa(F)
Figure 7. Transactivation by RARa Is Markedly Reduced by Muta-(lanes 7±10).
tion of Ser-77, Whereas It Is Increased by Overexpression of cdk7
(A) Cos-1 cells transfected with the mRARb2-CAT (5 mg) reporter
gene, without (lane 1) and with 50 ng of either RARaWT (lane 2),
RARaDAB (lane 3), RARaS74A (lane 4), RARaS77A (lane 5), RARaDF1±6) Note that all of the above RARa-cdk7/TFIIH interac-
(lane 6), RARaS449A (lane 7), RARaS456A (lane 8), or RARaS461A
tions similarly occurred irrespective of the presence of (lane 9) expression vectors, were treated (hatched bars) or not (open
RA (data not shown). bars) with RA (1027 M) for 20 hr. The results are the mean of three
independent experiments.
(B) Cos-1 cells were cotransfected with the mRARb2-CAT reporterEfficient Transactivation by RARa
gene, without (lane 1±3) or with either RARaWT (lanes 4±6), RARa-Requires Serine 77
S77A (lanes 7 and 8), or RARaDAB (lanes 9 and 10), and expressionThe possible role of phosphorylation by Pdks on trans-
vectors (0.5 mg) for cdk7 (lanes 2, 5, 8, and 10) or cdk1 (lanes 3 and
activation by RARa was investigated using RARaDAB 6). RA treatment and symbols are as in (A). The results are the mean
and RARaS→A mutants cotransfected in Cos-1 cells of three independent experiments.
with a RA-inducible RARb2 promoter-based reporter (C) Cos-1 cells were cotransfected with the DR1G-tk-CAT (1 mg)
reporter gene, without (lanes 1±3) or with increasing amounts (0.1,gene (mRARb2-CAT; Nagpal et al., 1992). Deletion of
0.2, and 0.5 mg) of RXRaWT (lanes 4±9), and with Cdk7 (0.5 mg) asthe A/B region abrogated the RA-induced enhancement
indicated (lanes 7±9). Cells were treated (lanes 2±9) or not (lane 1)of transcription from the RARb2 promoter (Figure 7A,
with 1027 M 9C-RA.
lane 3), in agreement with the previous report of Nagpal (D) Cos-1 cells were transfected with the 17m-ERE-Glob-CAT (5 mg)
et al. (1992), which established the importance of the reporter gene without (lanes 1±2) or with increasing amounts of G4-
AF-1 located in the A/B region for this enhancement. VP16 (5, 10, and 20 ng; lanes 3±8) or G4-Sp1 (0.1, 0.2, and 0.5 mg;
lanes 9±14). Cdk7 was cotransfected (lanes 2, 6±8, and 12±14).Most interestingly, the RARaS77A mutant also exhibited
a strongly reduced transcriptional activity (Figure 7A,
lane 5), while RARaDF (Durand et al., 1994), RARaS74A,
RARaS449A, RARaS456A, and RARaS461A were as ac- modified by cdk7 overexpression (Figure 7B, lanes 8 and
10), and that overexpression of cdk1 did not enhancetive as RARaWT (Figure 7A), thus strongly suggesting
that phosphorylation of Ser-77 is crucial for RARa AF-1 the transcriptional activity of RARa (Figure 7B, lane 6).
Similarly, overexpression of MAPKK did not increaseactivity, whereas phosphorylation of the region F sites
is dispensible. the activity of RARa (data not shown).
cdk7 overexpression did not modify the transcrip-That phosphorylation of Ser-77 by cdk7 could be re-
sponsible for the loss of transcriptional enhancement tional activity of RXRa on a DR1G-tk promoter that is
preferentially activated by RXR homodimers (Nagpal etby the RARaS77A mutant is supported by an increase
in the activity of the RARb2 promoter-based reporter al., 1992, and Figure 7C). Similarly, there was no en-
hanced transactivation of the 17m-ERE-Glob-CAT re-when RARaWT was cotransfected with a cdk7 expres-
sion vector (Figure 7B, compare lanes 4 and 5). This porter gene by the chimeric activators, GAL4-Sp1 and
GAL4-VP16 (Figure 7D), ruling out that cdk7 overexpres-increase was ligand-dependent and did not occur with
the mutant cdk7m (data not shown). Note that the tran- sion could result from a general enhancement of tran-
scription.scriptional activity of RARaS77A and RARaDAB was not
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Discussion phosphorylated in vitro, and the presence of the A/B
region appeared to prevent phosphorylation of the Ser
residues 445, 449, and 456. Interestingly, RARa was alsoWe have shown here that the serine residues of 5 out
of the 6 putative sites for Pdks present in RARa1 are phosphorylated in vitro by the purified general transcrip-
tion factor holoTFIIH, which contains the CAK complexphosphorylated when this receptor is expressed in
Cos-1 cells. One of these phosphorylation sites (Ser-77) associated with the numerous subunits of the TFIIH
core. It has recently been shown that TFIIH-associatedis located in the region A/B containing the activation
function AF-1, which has been shown to be required for CAK is more efficient than free CAK for phosphorylation
of some substrates in vitro (e.g., TFIIEa and the Pol IIefficient transactivation by RARa in transfected cells in
culture and, more recently, to play an essential role in largest subunit IIA; Rossignol et al., 1997; Yankulov and
Bentley, 1997). Similarly, we have shown here that RARathe RA-induced parietal endodermal differentiation of
F9 cells (Taneja et al., submitted), whereas the other is more efficiently phosphorylated by TFIIH than by free
CAK.sites (serines 445, 449, 456, and 461) are located in
region F, which appears to be dispensible.That mutation In marked contrast with the situation in transfected
Cos-1 cells, both serines 77 and 461 could be phosphor-of Ser-77 to Ala abrogates phosphorylation of the A/B
region and strongly decreases RARa transcriptional ylated in vitro by the cdk1/cyclin B complex, and Ser-
77 was also phosphorylated by MAPK.These discrepan-activity, together with the observation that enhanced
phosphorylation of Ser-77 stimulates AF1 activity, cies may correspond to a promiscuous activity of these
kinases in vitro; alternatively, and more interestingly,strongly supports the conclusion that AF-1 activity is
indeed critically dependent on Ser-77 phosphorylation. they may reflect the potential of cdk1 and MAPK to
phosphorylate RARa (notablySer-77 in theA/B region) inMost interestingly, our present study indicates that
phosphorylation of RARa Ser-77 could be linked to an cellular environments different from that of Cos-1 cells.
interaction between RARa and the transcription factor
TFIIH, thus providing the first exemple of activation of
RARa Interacts with cdk7 and the Generala transactivator through binding to and phosphorylation
Transcription Factor TFIIHby a general transcription factor. A similar interaction
The possibility that cdk7 could not only phosphorylateand phosphorylation may exist in the case of the RARg2
RARa, but also stably interact with it, was raised by theAF-1 domain, which is essential for F9 cell primitive
finding of overexpressed RARa in immunoprecipitatesendoderm differentiation and contains a Pdk site similar
of whole cell extracts of Cos-1 cells treated with cdk7to that characterized here for RARa (Taneja et al., sub-
antibodies. This possibility was further supported by themitted).
coimmunoprecipitation of endogenous RARa and cdk7
from HeLa cell nuclear extracts treated with either RARa
or cdk7 antibodies. Under similar conditions no coimmu-Phosphorylation of Ser-77 of the AF-1 Activating
Domain of RARa by CAK- and noprecipitation of RARa and either cdk1 or MAPKs
could be detected, thus providing strong support to theTFIIH-Associated cdk7
The highly conserved Pdk site present in the A/B region notion that cdk7 plays a unique role in RARa phosphory-
lation in vivo. That RARa and cdk7 directly interact wasof estrogen receptors is required for optimal activity of
AF-1 and is a target for phosphorylation by the Ras/ demonstrated by coimmunoprecipitation of the corre-
sponding purified recombinant proteins. Importantly,raf/MAP kinase cascade of the growth factor receptor
tyrosine kinase signaling pathway (Kato et al., 1995). neither the A/B region nor the integrity of the Ser-77
phosphorylation site were required for the above inter-However, we found no evidence for an in vivo involve-
ment of the MAPK cascade in phosphorylation of the actions, which were also not affected by the presence
of the ligand.RARa sites.
The observation that the pattern of phosphorylation We have shown that RARa can stably interact with
either free CAK or highly purified holoTFIIH in vitro. Fur-of RARa was independent of the phases of the cell
cycle prompted us to investigate whether the cyclin- thermore, our observations that an antibody against
RARa can coimmunoprecipitate both endogenous cdk7dependent kinase 7 (cdk7) could be involved in RARa
phosphorylation. Unlike those of the other cdks, the and the TFIIH core subunit p62 from HeLa cell nuclear
extracts, and reciprocally that an antibody against p62level and activity of cdk7 are constant during the various
phases of the cell cycle. Coexpression of cdk7 (but not can coimmunoprecipitate endogenous RARa and cdk7,
strongly suggests that at least a fraction of RARa isof cdk1) increased the level of RARa phosphorylation
in Cos-1 cells, and dominant-negative mutants of cdk1 associated with TFIIH in vivo. Moreover, our data indi-
cate that RARa interacts more efficiently with TFIIH-and cdk2 had no effect, thus indicating that cdk7 could
play a unique role in RARa phosphorylation. associated cdk7 than with cdk7 present in free CAK
complexes. Thus, the TFIIH ªenvironmentº may be moreThe activity of cdk7 is dependent on its association
with cyclin H and is stimulated by the association of favorable for RARa±cdk7 interaction than that of the
isolated CAK. Whether this reflects a modification of theMAT1 in the ternary CAK complex (see Results for refer-
ences). Accordingly, purified recombinant RARa was conformation of the CAK complex upon its association
with TFIIH (Adamczewski et al., 1996) or additional inter-phosphorylated in vitro by purified recombinant cdk7/
cyclin H complex, and the association of MAT1 (CAK action(s) between RARa and subunits of the TFIIH core
remains to be seen. In any event, our results indicatecomplex) enhanced this phosphorylation. However, only
Ser-77 in the B region and Ser-461 in the F region were that TFIIH-associated CAK rather than free CAK could
Activation of RARa through Phosphorylation by TFIIH
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be primilarly responsible for RARa phosphorylation. As How Could the RARa±TFIIH Interaction Be Involved
in Activation of Initiation of Transcription?the retinoid signal is transduced by RXR-RAR hetero-
dimers in vivo, it may be functionally relevant that cdk7 Activator proteins can stimulate initiation of transcrip-
tion in eukaryotes by acting at the level of the repressedwas also found associated with RXRa±RARa complexes
present in HeLa cell extracts. chromatin template and/or on the general machinery
responsible for class II gene transcription (Pol II and
GTFs). In the latter case, various steps can be stimu-Modulation of the Activity of RARa through
Phosphorylation by the General lated, and activators can function by (1) recruitment of
Pol II and GTFs to the promoter, (2) allosteric transcon-Transcription Factor TFIIH
Taken together, the observations (1) that the Ser-77A formation of already assembled preinitiation complexes,
(3) covalent modifications of GTFs, and (4) stimulationmutation markedly impairs the capability of RARa to
activate the RARb2 promoter, and (2) that this activation of promoter clearance. These effects may be caused by
direct interactions between activators and elements ofis enhanced by cdk7 overexpression (but not other cdks
or MAPK) while the level of Ser-77 phosphorylation is the general transcription machinery or may involve inter-
mediary factors (coactivators) relaying activator signalsconcomitantly increased, strongly support the conclu-
sion that the activity of RARa AF-1 requires the phos- to that machinery (Burley and Roeder, 1996; Goodrich
et al., 1996; Orphanides et al., 1996; Stargell and Struhl,phorylation of Ser-77 by cdk7, at least in Cos-1 cells.
As several lines of evidence support the conclusion that 1996; Struhl, 1996).
Several putative transcriptional intermediary factorsRARa is phosphorylated by cdk7 while bound to the
general transcription factor (GTF) TFIIH (see above), we (TIFs) that may relay the activity of the ligand-dependent
activation function AF-2 of a number of nuclear recep-therefore assume that overexpressionof cdk7 can result
in higher levels of holoTFIIH, leading to the formation tors onto the chromatin template or the general tran-
scription machinery have recently been isolated andof additional RARa±TFIIH complexes and enhanced
transcription. How RARa interacts with cdk7 within characterized, and most of them have been shown to
interact with RAR LBDs in a ligand-dependent mannerTFIIH remains to be investigated, but it is already clear
that both the N-terminal A/B region and the binding of (Chambon, 1996; Glass et al., 1997). However, the pres-
ent interaction between RARa and TFIIH does not ap-the RA ligand are not mandatory for this interaction.
cdk7 of TFIIH-associated CAK can phosphorylate two pear to require the N-terminal A/B region that contains
AF-1, nor the presence of the RA ligand. This excludesGTPs, TBP and TFIIEa, as well as the carboxy-terminal
domain (CTD) of the largest subunit IIA of Pol II, which that RARa AF-1 and AF-2 could be directly involved
in the recruitment of TFIIH, but does not rule out theappears to be required for the polymerase to enter an
elongation mode (Orphanides et al., 1996; Svejstrup et possibility that a cryptic, as yet uncharacterizedfunction
of RARa, could be involved in this recruitment. Alterna-al., 1996; Nikolov and Burley, 1997). Several transcrip-
tional activators, i.e., p53, VP16, Epstein-Barr virus nu- tively (or concomitantly), the interaction of RARa with
TFIIH may modulate the activity of the TFIIH-associatedclear protein 2, and the Hepatitis B virus activator HBX
(LeÂ veillard et al., 1996; Qadri et al., 1996; Warbrick, cdk7. This modulation may help in maintaining the Pol
II holoenzyme CTD in its unphosphorylated status within1996), appear to interact with various subunits of the
TFIIH core. It is unknown whether these proteins can the preinitiation complex, thereby preventing the poly-
merase to enter an elongation mode (BjoÈ rklund and Kim,be phosphorylated by TFIIH, but it is generally thought
that these interactions may lead to modulation of TFIIH 1996; Orphanides et al., 1996). Why the cdk7-mediated
phosphorylation of Ser-77 in the N-terminal region offunctions, e.g., phosphorylation of the Pol II CTD (Or-
phanides et al., 1996; Warbrick, 1996). Thus, our present RARa is critical for AF-1 activity, and more generally,
how AF-1 acts to enhance transcription, is unknown,findings introduce a new twist in the increasing com-
plexity of the mechanisms of transcriptional regulation as no interaction between the A/B region and GTFs or
putative intermediary factors (mediators) has yet beenin eukaryotes, i.e., the possibility to modulate the activity
of activators through the enzymatic activity of a general found. This question, and how the apparently ligand-
independent activation of AF-1 through phosphorylationtranscription factor. In this way, phosphorylation by the
TFIIH-associated cdk7 could provide an efficient mech- by TFIIH could be related to the overall ligand depen-
dence of transactivation by RARa, will require furtheranism for signaling between GTFs/Pol II (see above)
and transregulatory factors during the preinitiation and biochemical and genetic studies.
initiation steps. Whether cdk7 activity can be modified
Experimental Procedureswithin the TFIIHcomplex to differentially control the level
of RARa phosphorylation is unknown; however, it has
Plasmid Constructionsbeen shown that the specificity of CAK can be modified
pSG5-based expression vectors for mRARa1, mRARaDAB, mRAR-
upon its association with the TFIIH core (see above). In aDF (aT418), and mRXRa were previously described (Nagpal et
this respect, the known association of TFIIH with the al., 1992; Durand et al., 1994). RARaS74A and S77A in pSG5 were
Pol II holoenzyme multiprotein complex, which contains constructed by double PCR amplification (Rochette-Eglyet al., 1995)
to generate a MSCI/SacI fragment containing the mutation.additional GTFs and a mediator complex (BjoÈ rklund and
RARaS449A, RARaS445A, RARaS456A, andRARaS461A were simi-Kim, 1996; Orphanides et al., 1996), may generate addi-
larly constructed, generating a mutated EcoRV/XmaI fragment. Ad-tional possibilities for modulating the specificity/activity
ditional information and all oligonucleotide sequences are available
of cdk7, including those that may result from the binding upon request.
of these preinitiation complexes to promoters exhibiting The prokaryotic vectors pET3d RARaS77A and pET3d RARa-
S461A were constructed by subcloning KpnI/SacI and SacI/BamHIspecific features.
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